Newly reported from ESC 2024: Smoking Cessation Halves MACE Risk, Reduction Offers Little Protection
Newly reported from ESC 2024: Smoking Cessation Halves MACE Risk, Reduction Offers Little Protection Quitting smoking after a diagnosis of stable coronary artery disease (CAD) was linked to a nearly 50% reduction in the risk of major cardiovascular (CV) events, although cutting down smoking demonstrated little impact on CV risk, according to new research.1 These 5-year follow-up […]
ESC Congress 2024 Lipidology Preview, with Professor Kausik Ray
ESC Congress 2024 Lipidology Preview, with Professor Kausik Ray Boasting 12 Hot Line sessions, 26 late-breaking science sessions, 38 late-breaking trials, and more than 230 other sessions, the European Society of Cardiology (ESC) Congress 2024 has the potential to be 1 of the most influential cardiology meetings in recent memory. With the meeting headlined by anticipated data releases from […]
ESC Congress 2024 Clinical Trials to Watch, with Deepak Bhatt, MD, MPH, MBA
ESC Congress 2024 Clinical Trials to Watch, with Deepak Bhatt, MD, MPH, MBA Although both the American College of Cardiology and American Heart Association annual meetings are held in high esteem and renowned as platforms for sharing the latest clinically impactful and relevant research findings in cardiology, it is their European-based counterpart, the European Society […]
Newly reported from ACC 2024: Olezarsen Shows Ability to Reduce Triglycerides for Patients with FCS in BALANCE Trial
Newly reported from ACC 2024: Olezarsen Shows Ability to Reduce Triglycerides for Patients with FCS in BALANCE Trial A phase 3 trial of olezarsen suggests the APOC3 inhibitor could prove useful in the management of familial chylomicronemia syndrome (FCS). Results of the trial, called the BALANCE study, the olezarsen 80 mg monthly dose met the primary […]
Reporting from ACC 2024: Trends in Targeted Temperature Management Before and After 2013, with José López, MD
Reporting from ACC 2024: Trends in Targeted Temperature Management Before and After 2013, with José López, MD An analysis of data from the National Inpatient Sample over 15 years details the impact of the 2013 publication of the TTM trial on use of targeted temperature management (TTM) in the US. Presented at the American College of […]
From ACC 2024 – Laura Ross, PA-C: HeartBeet Clinic Offers Efficient, Reimbursable Avenue for Improving CV Risk Factors
From ACC 2024 – Laura Ross, PA-C: HeartBeet Clinic Offers Efficient, Reimbursable Avenue for Improving CV Risk Factors New data from the American College of Cardiology 2024 (ACC.24) Annual Scientific Session provide insight into the creation and reimbursement process for group visits to improve cardiovascular risk factors and lifestyle education. Dubbed the HeartBeet Clinic, the program leverages a food […]
Broadcasting from ACC 2024 – Ankeet Bhatt, MD, MBA: Sacubitril/Valsartan vs ACEi/ARB in de novo HFmrEF/HFpEF
Broadcasting from ACC 2024 – Ankeet Bhatt, MD, MBA: Sacubitril/Valsartan vs ACEi/ARB in de novo HFmrEF/HFpEF A comparative effectiveness analysis of data from the Optum Electronic Health Record dataset provides insight into the benefit of sacubitril/valsartan (Entresto) relative to angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) in patients with newly diagnosed heart failure with mildly reduced […]
Newscasting from ACC 2024 – Safia Chatur, MD: Sacubitril/Valsartan Offers Benefit in HFrEF Across New KDIGO Risk Classes
Newscasting from ACC 2024 – Safia Chatur, MD: Sacubitril/Valsartan Offers Benefit in HFrEF Across New KDIGO Risk Classes An analysis of data from PARADIGM-HF suggests sacubitril/valsartan (Entresto) provided consistent benefit across the spectrum of renal impairment among patients with heart failure with reduced ejection fraction (HFrEF). Presented at the American College of Cardiology 2024 (ACC.24) Annual Scientific […]
Reporting from ACC 2024 – Ankeet Bhatt, MD, MBA: NUDGE-FLU Analysis in Patients With and Without Myocardial Infarction
Reporting from ACC 2024 – Ankeet Bhatt, MD, MBA: NUDGE-FLU Analysis in Patients With and Without Myocardial Infarction Data from an analysis of the landmark NUDGE-FLU analysis offers insight into the effects of the study’s cardiovascular gains nudge on influenza vaccine uptake and outcomes based on history of acute myocardial infarction. Presented by Ankeet Bhatt, MD, […]
From ACC 2024: Understanding Trends in Hypertrophic Cardiomyopathy-Related ED Visits, with Ahmad Masri, MD, MS
From ACC 2024: Understanding Trends in Hypertrophic Cardiomyopathy-Related ED Visits, with Ahmad Masri, MD, MS Insights from an analysis of the Nationwide Emergency Department Sample (NEDS) from 2006 through 2019 provides a snapshot of trends in emergency department visits among patients with hypertrophic cardiomyopathy (HCM) in the US. Presented at the American College of Cardiology 2024 (ACC.24) Annual […]
